IBSA Quality Approach
MADE IN EU
From the selection of raw materials to production innovation, IBSA has demonstrated a steadfast commitment to the pursuit of advanced and safe therapeutic solutions.
IBSA is one of the world’s leading producers of hyaluronic acid (HA) through biofermentation, an innovative and efficient process that ensures of the product.
The company has differentiated itself in the market with an offering that spans three generations of products, from linear hyaluronic acid to innovative hybrid formulations obtained through NAHYCO® Hybrid technology, an exclusive patent of IBSA.
The medical devices for joint viscosupplementation marketed by IBSA are produced in Europe and are the result of the company’s ongoing investment in innovation, research and development aimed at providing increasingly targeted solutions for the needs of doctors and different kind of patients, including athletes.
Viscosupplementation indeed finds multiple applications in sports medicine and rehabilitation: athletes are particularly subjected to continuous stresses, which can lead to significant diagnostic pictures even at a very young age.
IBSA, a company sensitive to the needs of athletes and the ethical value of sports, promotes a rigorous anti-doping policy that values and rewards discipline and the ethics of healthy competition among athletes.
IBSA’s hyaluronic acid-based products for joint viscosupplementation were the first to receive, in 2020, the Play Sure Doping Free certification, which guarantees the absence of doping substances. This commitment was further recognized in 2022 with the No Doping Life award, given to IBSA as a virtuous company in the fight against doping.
